Assembly Biosciences (ASMB) Earnings Analysis
Assembly Biosciences (ASMB) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS -0.54 USD vs -0.73 USD est (+26%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -44.90.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ASMB next report earnings?
No confirmed upcoming earnings date is currently scheduled for ASMB. This page updates as the calendar is published.
ASMB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.54 USD | -0.73 USD | +26% | Beat |
| 2026-03-19 | 2.48 USD | -0.51 USD | +586.3% | Beat |
| 2025-11-10 | -0.72 USD | -0.5 USD | -44% | Miss |
| 2025-03-20 | -1.57 USD | -1.75 USD | +10.3% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
ASMB valuation and analyst view
| Trailing P/E | -44.90 |
|---|---|
| Trailing EPS | -0.37769 USD |
| Price / book | 2.22 |
| Dividend yield | 0.00% |
| Market cap | 0.41B |
| Analyst consensus | Buy (6 buy / 5 hold / 0 sell) |
| Avg price target | 45 USD |
Related research pages
Frequently asked questions
When is Assembly Biosciences (ASMB)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ASMB. This page updates as the calendar is published.
Did ASMB beat earnings last quarter?
In its 2026-05-07 report, ASMB posted EPS of -0.54 USD versus a -0.73 USD estimate — a beat of 26%.
What is ASMB's earnings track record?
Over the last 4 reported quarters with consensus data, ASMB beat estimates 3 times (75%).
What is ASMB's current P/E ratio and EPS?
ASMB trades at a trailing P/E of -44.90 on trailing EPS of -0.37768712287499956 USD.
What do analysts rate ASMB?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 6 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 45 USD.